Aclarion, Inc. (ACON) Insider Trading & SEC Filings
Last SEC filing
Aclarion, Inc. (ACON) has filed 13 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-12. Insiders disclosed 4 open-market purchases totaling $51K. 1 Form 8-K material event filing was reported by ACON in the last 90 days. InsiderAlpha tracks every ACON SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Aclarion, Inc. (ACON)
Aclarion, Inc. trades under the ticker ACON. InsiderAlpha tracks 15 primary SEC Form 4 filings from 9 reporting insiders for ACON since 2025, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Services-Medical Laboratories (SIC 8071) |
| SEC CIK | 0001635077 |
90-Day SEC Filing Activity
| Insider purchases (90d) | 4 ($51K) |
|---|---|
| Form 4 filings (90d) | 13 |
| Form 8-K filings (90d) | 1 |
| Latest Form 4 filing | 2026-06-12 |
Recent ACON Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Stephen Deitsch | Director | A - Grant or award | 20.0K | $0.00 | - | SEC | |
| Gregory A. Gould | Chief Financial Officer | A - Grant or award | 50.0K | $0.00 | - | SEC | |
| Brent Ness | Chief Executive Officer | A - Grant or award | 100.0K | $0.00 | - | SEC | |
| William Wesemann | Director | A - Grant or award | 20.0K | $0.00 | - | SEC | |
| Jeffrey John Thramann | Executive Chairman | A - Grant or award | 100.0K | $0.00 | - | SEC | |
| David K. Neal | Director | A - Grant or award | 20.0K | $0.00 | - | SEC | |
| Ryan Bond | Chief Strategy Officer | A - Grant or award | 55.0K | $0.00 | - | SEC | |
| Amanda Mae Sequira | Director | A - Grant or award | 20.0K | $0.00 | - | SEC | |
| Scott Breidbart | Director | A - Grant or award | 20.0K | $0.00 | - | SEC | |
| Scott Breidbart | Director | P - Open-market purchase | 5.7K | $3.18 | $18K | SEC | |
| Brent Ness | Chief Executive Officer | P - Open-market purchase | 6.3K | $3.18 | $20K | SEC | |
| David K. Neal | Director | P - Open-market purchase | 2.5K | $3.10 | $8K | SEC | |
| William Wesemann | Director | P - Open-market purchase | 1.6K | $3.30 | $5K | SEC | |
| Brent Ness | Chief Executive Officer | P - Open-market purchase | 10 | $6.20 | $62 | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Aclarion, Inc. (ACON). Updated in real time as new filings are submitted to the SEC.
Most-Active ACON Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| William Wesemann | 2 | $5K |
| Brent Ness | 2 | $20K |
| David K. Neal | 2 | $8K |
| Scott Breidbart | 2 | $18K |
| Amanda Mae Sequira | 1 | - |
Recent ACON Form 8-K Material Events
- - Item 5.07 [SEC]
- - Item 8.01, 9.01 · Other · neutral [SEC]
Aclarion's board of directors authorized a share repurchase program allowing the company to buy back up to $2.5 million of its common stock over the next 12 months. The program is discretionary and may be executed through various methods including open market purchases, privately - - Item 1.01, 3.03, 5.03, 8.01, 9.01 · Legal · neutral [SEC]
Aclarion's board of directors adopted a stockholder rights agreement (poison pill) on March 19, 2026, declaring a dividend of one Right per outstanding share of common stock and warrants to shareholders of record on March 30, 2026. Each Right entitles holders to purchase one one-
Recent Insider Filings
- - Ryan Bond (Chief Strategy Officer)
- - Amanda Mae Sequira (Director)
- - Scott Breidbart (Director)
- - Gregory A. Gould (Chief Financial Officer)
- - Brent Ness (Chief Executive Officer)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ACON insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
ACON Insider Trading - FAQ
- What is the latest insider trade for ACON?
- Aclarion, Inc. (ACON) had 13 insider filings in the last 90 days, with the most recent on 2026-06-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying ACON stock?
- 4 insider purchases of ACON were filed in the last 90 days, totaling $51K.
- How many insiders are selling ACON stock?
- 0 insider sales of ACON were filed in the last 90 days.
- Where can I see ACON SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks ACON Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $AEMD AETHLON MEDICAL INC
- $AHCO AdaptHealth Corp.
- $AIM AIM ImmunoTech Inc.
- $AKTX Akari Therapeutics Plc
- $ALMS ALUMIS INC.
- $ANNX Annexon, Inc.
- $APGE Apogee Therapeutics, Inc.
- $APVO Aptevo Therapeutics Inc.
- $ARTL ARTELO BIOSCIENCES, INC.
- $ARTV Artiva Biotherapeutics, Inc.
Related Companies - Recent Insider Activity
- Guardant Health, Inc. (GH)
- Natera, Inc. (NTRA)
- CASTLE BIOSCIENCES INC (CSTL)
- QUEST DIAGNOSTICS INC (DGX)
- SERA PROGNOSTICS, INC. (SERA)
- CareDx, Inc. (CDNA)
- VERACYTE, INC. (VCYT)
- Personalis, Inc. (PSNL)
- Fulgent Genetics, Inc. (FLGT)
- Fortrea Holdings Inc. (FTRE)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live ACON dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.